April 7, 2014 / 11:12 AM / 3 years ago

Mallinckrodt to buy Questcor Pharma for about $5.6 bln

1 Min Read

April 7 (Reuters) - Specialty pharmaceuticals company Mallinckrodt Plc agreed to buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its multiple sclerosis drug, Acthar Gel.

Questcor's shareholders will receive $30 in cash and 0.897 Mallinckrodt shares for each Questcor share held, for a total value of about $86.10 per Questcor share, the companies said in a joint statement. (Reporting by Esha Dey in Bangalore; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below